Skip to content

Bebida Beverage Company controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2015

    FDA action over Koma Unwind labeling and melatonin

    The FDA issued a warning letter concerning Koma Unwind’s labeling and the use of melatonin in a beverage. The agency questioned the product’s treatment as a supplement while it was marketed and sold as a drink, and reported sales were halted while corrective action was pursued.